Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00433459

Recruitment Status : Completed

First Posted : February 12, 2007

Last Update Posted : March 26, 2020

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

Deutsche Krebshilfe e.V., Bonn (Germany)

Euronet Worldwide

Information provided by (Responsible Party):

Christine Mauz-Körholz, Martin-Luther-Universität Halle-Wittenberg

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	January 2013
Actual Study Completion Date :	January 2013

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Mauz-Korholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernandez-Teijeiro A, Fossa A, Gattenlohner S, Georgi T, Hjalgrim LL, Hraskova A, Karlen J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajic V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Korholz D, Hasenclever D, Wallace WH. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 9. Erratum In: Lancet Oncol. 2022 Feb;23(2):e59.

To Top